Akèy › Obèsite › North Carolina › Greensboro
Etid klinik pou Obèsite nan Greensboro, NC
12 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Greensboro (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Moses H Cone Memorial Hospital, Greensboro
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Medication Management /ID# 281965, Greensboro
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- Medication Management, LLC, Greensboro
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- PharmQuest Life Sciences LLC, Greensboro
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- Medication Mgmnt, LLC_Grnsboro, Greensboro
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- PharmQuest Life Sciences LLC, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Medication Management, Greensboro
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- PharmQuest Life Sciences, LLC, Greensboro
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Medication Management, Greensboro
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- Medication Management, Greensboro
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Ap rekriteFaz 3
- PharmQuest, Greensboro
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Greensboro
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL32 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD26 etid
- Jacksonville, FL25 etid
Lòt etid nan Greensboro
- Sipwa12 etid
- Dyabèt Tip 26 etid
- Ensifizyans kadyak6 etid
- Kansè nan tete5 etid
- Maladi kadyovaskilè5 etid
- VIH4 etid
- Akidan serebavaskilè4 etid
- Maladi poumon entèstisyèl4 etid
- Atak kè4 etid
- Kansè poumon3 etid
- Fibroz Pulmonè Idyopatik3 etid
- Ateroskleroz3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.